This report aims to provide a comprehensive presentation of the global market for Non-invasive Cancer Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Cancer Diagnosis. This report contains market size and forecasts of Non-invasive Cancer Diagnosis in global, including the following market information:
Global Non-invasive Cancer Diagnosis Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Non-invasive Cancer Diagnosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Clinical Chemistry Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-invasive Cancer Diagnosis include Gen-Probe Inc., A&G Pharmaceutical, Affymetrix Inc., Digene Corporation, Quest Diagnostics Inc., BioView Inc., LabCorp, AVIVA Biosciences Corporation and Precision Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-invasive Cancer Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-invasive Cancer Diagnosis Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Non-invasive Cancer Diagnosis Market Segment Percentages, by Type, 2022 (%)
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others
Global Non-invasive Cancer Diagnosis Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Non-invasive Cancer Diagnosis Market Segment Percentages, by Application, 2022 (%)
Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Others
Global Non-invasive Cancer Diagnosis Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Non-invasive Cancer Diagnosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-invasive Cancer Diagnosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non-invasive Cancer Diagnosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gen-Probe Inc.
A&G Pharmaceutical
Affymetrix Inc.
Digene Corporation
Quest Diagnostics Inc.
BioView Inc.
LabCorp
AVIVA Biosciences Corporation
Precision Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-invasive Cancer Diagnosis, market overview.
Chapter 2: Global Non-invasive Cancer Diagnosis market size in revenue.
Chapter 3: Detailed analysis of Non-invasive Cancer Diagnosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-invasive Cancer Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-invasive Cancer Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-invasive Cancer Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-invasive Cancer Diagnosis Overall Market Size
2.1 Global Non-invasive Cancer Diagnosis Market Size: 2022 VS 2030
2.2 Global Non-invasive Cancer Diagnosis Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-invasive Cancer Diagnosis Players in Global Market
3.2 Top Global Non-invasive Cancer Diagnosis Companies Ranked by Revenue
3.3 Global Non-invasive Cancer Diagnosis Revenue by Companies
3.4 Top 3 and Top 5 Non-invasive Cancer Diagnosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-invasive Cancer Diagnosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-invasive Cancer Diagnosis Players in Global Market
3.6.1 List of Global Tier 1 Non-invasive Cancer Diagnosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-invasive Cancer Diagnosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-invasive Cancer Diagnosis Market Size Markets, 2022 & 2030
4.1.2 Clinical Chemistry
4.1.3 Immunochemistry/Immunoassay
4.1.4 Molecular Diagnostics
4.1.5 Others
4.2 By Type - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
4.2.1 By Type - Global Non-invasive Cancer Diagnosis Revenue, 2018-2023
4.2.2 By Type - Global Non-invasive Cancer Diagnosis Revenue, 2024-2030
4.2.3 By Type - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-invasive Cancer Diagnosis Market Size, 2022 & 2030
5.1.2 Blood Cancer
5.1.3 Solid Tumors
5.1.4 Breast Cancer
5.1.5 Lung Cancer
5.1.6 Others
5.2 By Application - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
5.2.1 By Application - Global Non-invasive Cancer Diagnosis Revenue, 2018-2023
5.2.2 By Application - Global Non-invasive Cancer Diagnosis Revenue, 2024-2030
5.2.3 By Application - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Non-invasive Cancer Diagnosis Market Size, 2022 & 2030
6.2 By Region - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
6.2.1 By Region - Global Non-invasive Cancer Diagnosis Revenue, 2018-2023
6.2.2 By Region - Global Non-invasive Cancer Diagnosis Revenue, 2024-2030
6.2.3 By Region - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.3.2 US Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.3.3 Canada Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.3.4 Mexico Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.4.2 Germany Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.3 France Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.4 U.K. Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.5 Italy Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.6 Russia Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.7 Nordic Countries Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.8 Benelux Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.5.2 China Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5.3 Japan Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5.4 South Korea Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5.5 Southeast Asia Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5.6 India Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.6.2 Brazil Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.6.3 Argentina Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.7.2 Turkey Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.7.3 Israel Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.7.4 Saudi Arabia Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.7.5 UAE Non-invasive Cancer Diagnosis Market Size, 2018-2030
7 Non-invasive Cancer Diagnosis Companies Profiles
7.1 Gen-Probe Inc.
7.1.1 Gen-Probe Inc. Company Summary
7.1.2 Gen-Probe Inc. Business Overview
7.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.1.4 Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.1.5 Gen-Probe Inc. Key News & Latest Developments
7.2 A&G Pharmaceutical
7.2.1 A&G Pharmaceutical Company Summary
7.2.2 A&G Pharmaceutical Business Overview
7.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Major Product Offerings
7.2.4 A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.2.5 A&G Pharmaceutical Key News & Latest Developments
7.3 Affymetrix Inc.
7.3.1 Affymetrix Inc. Company Summary
7.3.2 Affymetrix Inc. Business Overview
7.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.3.4 Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.3.5 Affymetrix Inc. Key News & Latest Developments
7.4 Digene Corporation
7.4.1 Digene Corporation Company Summary
7.4.2 Digene Corporation Business Overview
7.4.3 Digene Corporation Non-invasive Cancer Diagnosis Major Product Offerings
7.4.4 Digene Corporation Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.4.5 Digene Corporation Key News & Latest Developments
7.5 Quest Diagnostics Inc.
7.5.1 Quest Diagnostics Inc. Company Summary
7.5.2 Quest Diagnostics Inc. Business Overview
7.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.5.4 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.5.5 Quest Diagnostics Inc. Key News & Latest Developments
7.6 BioView Inc.
7.6.1 BioView Inc. Company Summary
7.6.2 BioView Inc. Business Overview
7.6.3 BioView Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.6.4 BioView Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.6.5 BioView Inc. Key News & Latest Developments
7.7 LabCorp
7.7.1 LabCorp Company Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Non-invasive Cancer Diagnosis Major Product Offerings
7.7.4 LabCorp Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.7.5 LabCorp Key News & Latest Developments
7.8 AVIVA Biosciences Corporation
7.8.1 AVIVA Biosciences Corporation Company Summary
7.8.2 AVIVA Biosciences Corporation Business Overview
7.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Major Product Offerings
7.8.4 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.8.5 AVIVA Biosciences Corporation Key News & Latest Developments
7.9 Precision Therapeutics
7.9.1 Precision Therapeutics Company Summary
7.9.2 Precision Therapeutics Business Overview
7.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Major Product Offerings
7.9.4 Precision Therapeutics Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.9.5 Precision Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Non-invasive Cancer Diagnosis Market Opportunities & Trends in Global Market
Table 2. Non-invasive Cancer Diagnosis Market Drivers in Global Market
Table 3. Non-invasive Cancer Diagnosis Market Restraints in Global Market
Table 4. Key Players of Non-invasive Cancer Diagnosis in Global Market
Table 5. Top Non-invasive Cancer Diagnosis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Non-invasive Cancer Diagnosis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Non-invasive Cancer Diagnosis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Non-invasive Cancer Diagnosis Product Type
Table 9. List of Global Tier 1 Non-invasive Cancer Diagnosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-invasive Cancer Diagnosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Non-invasive Cancer Diagnosis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Non-invasive Cancer Diagnosis Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Non-invasive Cancer Diagnosis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Non-invasive Cancer Diagnosis Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Non-invasive Cancer Diagnosis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Non-invasive Cancer Diagnosis Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2024-2030
Table 30. Gen-Probe Inc. Company Summary
Table 31. Gen-Probe Inc. Non-invasive Cancer Diagnosis Product Offerings
Table 32. Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 33. Gen-Probe Inc. Key News & Latest Developments
Table 34. A&G Pharmaceutical Company Summary
Table 35. A&G Pharmaceutical Non-invasive Cancer Diagnosis Product Offerings
Table 36. A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 37. A&G Pharmaceutical Key News & Latest Developments
Table 38. Affymetrix Inc. Company Summary
Table 39. Affymetrix Inc. Non-invasive Cancer Diagnosis Product Offerings
Table 40. Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 41. Affymetrix Inc. Key News & Latest Developments
Table 42. Digene Corporation Company Summary
Table 43. Digene Corporation Non-invasive Cancer Diagnosis Product Offerings
Table 44. Digene Corporation Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 45. Digene Corporation Key News & Latest Developments
Table 46. Quest Diagnostics Inc. Company Summary
Table 47. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product Offerings
Table 48. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 49. Quest Diagnostics Inc. Key News & Latest Developments
Table 50. BioView Inc. Company Summary
Table 51. BioView Inc. Non-invasive Cancer Diagnosis Product Offerings
Table 52. BioView Inc. Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 53. BioView Inc. Key News & Latest Developments
Table 54. LabCorp Company Summary
Table 55. LabCorp Non-invasive Cancer Diagnosis Product Offerings
Table 56. LabCorp Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 57. LabCorp Key News & Latest Developments
Table 58. AVIVA Biosciences Corporation Company Summary
Table 59. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product Offerings
Table 60. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 61. AVIVA Biosciences Corporation Key News & Latest Developments
Table 62. Precision Therapeutics Company Summary
Table 63. Precision Therapeutics Non-invasive Cancer Diagnosis Product Offerings
Table 64. Precision Therapeutics Non-invasive Cancer Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 65. Precision Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Non-invasive Cancer Diagnosis Segment by Type in 2022
Figure 2. Non-invasive Cancer Diagnosis Segment by Application in 2022
Figure 3. Global Non-invasive Cancer Diagnosis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-invasive Cancer Diagnosis Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Non-invasive Cancer Diagnosis Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-invasive Cancer Diagnosis Revenue in 2022
Figure 8. By Type - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 9. By Application - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 10. By Type - Global Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 12. By Application - Global Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 14. By Region - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 15. By Country - North America Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 16. US Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 20. Germany Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 21. France Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 28. China Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 32. India Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 34. Brazil Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
Figure 37. Turkey Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Non-invasive Cancer Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 41. Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Digene Corporation Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BioView Inc. Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. LabCorp Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Precision Therapeutics Non-invasive Cancer Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
